Sequana and its subsidiary Antalis have experienced worse business than last year during the current financial year. Antalis booked a 2.2% slump in sales to €1.73bn in the first nine months of this year. Its EBITDA tumbled a little over 15% to €50.3m. Operating income plunged 28% to €32.9m. The firm’s ...
Read more
You can only use this article with a valid subscription and registration. Registered subscribers can access all articles after entering their user name and password.
- Ad -
